Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David W Dunne

Showing results (101-110 of 113) with videos related to

Pageof 12
Sort By:
The Journal of Infectious Diseases|July 24, 2004
Increases in human T helper 2 cytokine responses to Schistosoma mansoni worm and worm-tegument antigens are induced by treatment with praziquantelSarah Joseph, Frances M Jones, Klaudia Walter, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|December 20, 2005
Applied and basic research on the epidemiology, morbidity, and immunology of schistosomiasis in fishing communities on Lake Albert, UgandaDavid W Dunne, Birgitte J Vennervald, Mark Booth, et al.
The Journal of Infectious Diseases|March 28, 2003
Juvenile rhesus monkeys have lower type 2 cytokine responses than adults after primary infection with Schistosoma mansoniPadraic G Fallon, Jason Gibbons, Richard A Vervenne, et al.
Plos Neglected Tropical Diseases|March 9, 2022
Increased ShTAL1 IgE responses post-Praziquantel treatment may be associated with a reduced risk to re-infection in a Ghanaian S. haematobium-endemic communityElias K Asuming-Brempong, Irene Ayi, William van der Puije, et al.
Parasite Immunology|September 22, 2018
Antibody responses to Schistosoma mansoni schistosomula antigensMoses Egesa, Lawrence Lubyayi, Frances M Jones, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|August 30, 2014
Maternal hookworm modifies risk factors for childhood eczema: results from a birth cohort in UgandaHarriet Mpairwe, Juliet Ndibazza, Emily L Webb, et al.
Infection and Immunity|June 24, 2004
Chemotherapy for schistosomiasis in Ugandan fishermen: treatment can cause a rapid increase in interleukin-5 levels in plasma but decreased levels of eosinophilia and worm-specific immunoglobulin EColin M Fitzsimmons, Sarah Joseph, Frances M Jones, et al.
Plos Neglected Tropical Diseases|September 26, 2014
Use of humanised rat basophilic leukaemia cell line RS-ATL8 for the assessment of allergenicity of Schistosoma mansoni proteinsDaniel Wan, Fernanda Ludolf, Daniel G W Alanine, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 31, 2003
IL-13 receptor alpha 2 down-modulates granulomatous inflammation and prolongs host survival in schistosomiasisMargaret M Mentink-Kane, Allen W Cheever, Robert W Thompson, et al.
American Journal of Respiratory and Critical Care Medicine|August 27, 2015
Hepatic Shunting of Eggs and Pulmonary Vascular Remodeling in Bmpr2(+/-) Mice with SchistosomiasisAlexi Crosby, Elaine Soon, Frances M Jones, et al.
Pageof 12

Showing results (101-110 of 113) with videos related to

Sort By:
Pageof 12
The Journal of Infectious Diseases|July 24, 2004
Increases in human T helper 2 cytokine responses to Schistosoma mansoni worm and worm-tegument antigens are induced by treatment with praziquantelSarah Joseph, Frances M Jones, Klaudia Walter, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|December 20, 2005
Applied and basic research on the epidemiology, morbidity, and immunology of schistosomiasis in fishing communities on Lake Albert, UgandaDavid W Dunne, Birgitte J Vennervald, Mark Booth, et al.
The Journal of Infectious Diseases|March 28, 2003
Juvenile rhesus monkeys have lower type 2 cytokine responses than adults after primary infection with Schistosoma mansoniPadraic G Fallon, Jason Gibbons, Richard A Vervenne, et al.
Plos Neglected Tropical Diseases|March 9, 2022
Increased ShTAL1 IgE responses post-Praziquantel treatment may be associated with a reduced risk to re-infection in a Ghanaian S. haematobium-endemic communityElias K Asuming-Brempong, Irene Ayi, William van der Puije, et al.
Parasite Immunology|September 22, 2018
Antibody responses to Schistosoma mansoni schistosomula antigensMoses Egesa, Lawrence Lubyayi, Frances M Jones, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|August 30, 2014
Maternal hookworm modifies risk factors for childhood eczema: results from a birth cohort in UgandaHarriet Mpairwe, Juliet Ndibazza, Emily L Webb, et al.
Infection and Immunity|June 24, 2004
Chemotherapy for schistosomiasis in Ugandan fishermen: treatment can cause a rapid increase in interleukin-5 levels in plasma but decreased levels of eosinophilia and worm-specific immunoglobulin EColin M Fitzsimmons, Sarah Joseph, Frances M Jones, et al.
Plos Neglected Tropical Diseases|September 26, 2014
Use of humanised rat basophilic leukaemia cell line RS-ATL8 for the assessment of allergenicity of Schistosoma mansoni proteinsDaniel Wan, Fernanda Ludolf, Daniel G W Alanine, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 31, 2003
IL-13 receptor alpha 2 down-modulates granulomatous inflammation and prolongs host survival in schistosomiasisMargaret M Mentink-Kane, Allen W Cheever, Robert W Thompson, et al.
American Journal of Respiratory and Critical Care Medicine|August 27, 2015
Hepatic Shunting of Eggs and Pulmonary Vascular Remodeling in Bmpr2(+/-) Mice with SchistosomiasisAlexi Crosby, Elaine Soon, Frances M Jones, et al.
Pageof 12